Exome Sequencing and Congenital Heart Disease in Sub-Saharan Africa,Circulation: Genomic and Precision Medicine

当前位置： X-MOL 学术 › Circ. Genom. Precis. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Exome Sequencing and Congenital Heart Disease in Sub-Saharan Africa
Circulation: Genomic and Precision Medicine ( IF 6.0 ) Pub Date : 2021-01-15 , DOI: 10.1161/circgen.120.003108
Ekanem N Ekure ₁ , Adebowale Adeyemo ₂ , Hanhan Liu ₃ , Ogochukwu Sokunbi ₁ , Nnenna Kalu ₁ , Ariel F Martinez ₄ , Babajide Owosela ₄ , Cedrik Tekendo-Ngongang ₄ , Yonit A Addissie ₄ , Akinsanya Olusegun-Joseph ₅ , Desmond Ikebudu ₆ , Seth I Berger ₇ , Maximilian Muenke ₄ , Zhe Han ₃ , Paul Kruszka ₄

Affiliation

Background:Congenital heart disease (CHD) is the most common birth defect and affects roughly 1% of the global population. There have been many large CHD sequencing projects in developing countries but none in sub-Saharan Africa. In this exome sequencing study, we recruited families from Lagos, Nigeria, affected by structural heart disease.Methods:Ninety-eight participants with CHD and an average age of 3.6 years were recruited from Lagos, Nigeria. Exome sequencing was performed on probands and parents when available. For genes of high interest, we conducted functional studies in Drosophila using a cardiac-specific RNA interference–based gene silencing system.Results:The 3 most common CHDs were tetralogy of Fallot (20%), isolated ventricular septal defect (14%), and transposition of the great arteries (8%). Ten percent of the cohort had pathogenic or likely pathogenic variants in genes known to cause CHD. In 64 complete trios, we found 34 de novo variants that were not present in the African population in the Genome Aggregation Database (v3). Nineteen loss of function variants were identified using the genome-wide distribution of selection effects for heterozygous protein-truncating variants (s_het). Nine genes caused a significant mortality when silenced in the Drosophila heart, including 4 novel disease genes not previously associated with CHD (UBB, EIF4G3, SREBF1, and METTL23).Conclusions:This study identifies novel candidate genes and variants for CHD and facilitates comparisons with previous CHD sequencing studies in predominantly European cohorts. The study represents an important first step in genomic studies of CHD in understudied populations.Registration:URL: https://www.clinicaltrials.gov; Unique identifier: NCT01952171.

更新日期：2021-02-17

点击分享查看原文

点击收藏

阅读更多本刊最新论文